Global Oncology Biosimilars Market Report 2021
At the beginning of 2020, COVID-19 disease began to spread around the world, millions of people worldwide were infected with COVID-19 disease, and major countries around the world have implemented foot prohibitions and work stoppage orders. Except for the medical supplies and life support products industries, most industries have been greatly impacted, and Oncology Biosimilars industries have also been greatly affected.
In the past few years, the Oncology Biosimilars market experienced a growth of 7, the global market size of Oncology Biosimilars reached (2020 Market size XXXX) million $ in 2020, of what is about (2015 Market size XXXX) million $ in 2015.
From 2015 to 2019, the growth rate of global Oncology Biosimilars market size was in the range of xxx%. At the end of 2019, COVID-19 began to erupt in China, Due to the huge decrease of global economy; we forecast the growth rate of global economy will show a decrease of about 4%, due to this reason, Oncology Biosimilars market size in 2020 will be (2020 Market size XXXX) with a growth rate of xxx%. This is xxx percentage points lower than in previous years.
As of the date of the report, there have been more than 20 million confirmed cases of CVOID-19 worldwide, and the epidemic has not been effectively controlled. Therefore, we predict that the global epidemic will be basically controlled by the end of 2020 and the global Oncology Biosimilars market size will reach (2025 Market size XXXX) million $ in 2025, with a CAGR of xxx% between 2020-2025.
This Report covers the manufacturers’ data, including: shipment, price, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the competitors better. This report also covers all the regions and countries of the world, which shows a regional development status, including market size, volume and value, as well as price data.
Besides, the report also covers segment data, including: type segment, industry segment, channel segment etc. cover different segment market size, both volume and value. Also cover different industries clients information, which is very important for the manufacturers.
Section 1: Free——Definition
Section (2 3): 1200 USD——Manufacturer Detail
Celltrion Inc.
BioconSTADA Arzneimittel AG
Dr. Reddy’s Laboratories Ltd.
Pfizer Inc.
Intas Pharmaceuticals Ltd.
Sandoz International GmbH
BIOCAD
Teva Pharmaceutical Industries Ltd.
Section 4: 900 USD——Region Segmentation
North America Country (United States, Canada)
South America
Asia Country (China, Japan, India, Korea)
Europe Country (Germany, UK, France, Italy)
Other Country (Middle East, Africa, GCC)
Section (5 6 7): 500 USD——
Product Type Segmentation
Drug Class - G-CSF
Monoclonal Antibodies
Hematopoietic Agents
Industry Segmentation
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Channel (Direct Sales, Distributor) Segmentation
Section 8: 400 USD——Trend (2020-2025)
Section 9: 300 USD——Product Type Detail
Section 10: 700 USD——Downstream Consumer
Section 11: 200 USD——Cost Structure
Section 12: 500 USD——Conclusion
Section 1 Oncology Biosimilars Product Definition
Section 2 Global Oncology Biosimilars Market Manufacturer Share and Market Overview
2.1 Global Manufacturer Oncology Biosimilars Shipments
2.2 Global Manufacturer Oncology Biosimilars Business Revenue
2.3 Global Oncology Biosimilars Market Overview
2.4 COVID-19 Impact on Oncology Biosimilars Industry
Section 3 Manufacturer Oncology Biosimilars Business Introduction
3.1 Celltrion Inc. Oncology Biosimilars Business Introduction
3.1.1 Celltrion Inc. Oncology Biosimilars Shipments, Price, Revenue and Gross profit 2015-2020
3.1.2 Celltrion Inc. Oncology Biosimilars Business Distribution by Region
3.1.3 Celltrion Inc. Interview Record
3.1.4 Celltrion Inc. Oncology Biosimilars Business Profile
3.1.5 Celltrion Inc. Oncology Biosimilars Product Specification
3.2 BioconSTADA Arzneimittel AG Oncology Biosimilars Business Introduction
3.2.1 BioconSTADA Arzneimittel AG Oncology Biosimilars Shipments, Price, Revenue and Gross profit 2015-2020
3.2.2 BioconSTADA Arzneimittel AG Oncology Biosimilars Business Distribution by Region
3.2.3 Interview Record
3.2.4 BioconSTADA Arzneimittel AG Oncology Biosimilars Business Overview
3.2.5 BioconSTADA Arzneimittel AG Oncology Biosimilars Product Specification
3.3 Dr. Reddy’s Laboratories Ltd. Oncology Biosimilars Business Introduction
3.3.1 Dr. Reddy’s Laboratories Ltd. Oncology Biosimilars Shipments, Price, Revenue and Gross profit 2015-2020
3.3.2 Dr. Reddy’s Laboratories Ltd. Oncology Biosimilars Business Distribution by Region
3.3.3 Interview Record
3.3.4 Dr. Reddy’s Laboratories Ltd. Oncology Biosimilars Business Overview
3.3.5 Dr. Reddy’s Laboratories Ltd. Oncology Biosimilars Product Specification
3.4 Pfizer Inc. Oncology Biosimilars Business Introduction
3.5 Intas Pharmaceuticals Ltd. Oncology Biosimilars Business Introduction
3.6 Sandoz International GmbH Oncology Biosimilars Business Introduction
…
Section 4 Global Oncology Biosimilars Market Segmentation (Region Level)
4.1 North America Country
4.1.1 United States Oncology Biosimilars Market Size and Price Analysis 2015-2020
4.1.2 Canada Oncology Biosimilars Market Size and Price Analysis 2015-2020
4.2 South America Country
4.2.1 South America Oncology Biosimilars Market Size and Price Analysis 2015-2020
4.3 Asia Country
4.3.1 China Oncology Biosimilars Market Size and Price Analysis 2015-2020
4.3.2 Japan Oncology Biosimilars Market Size and Price Analysis 2015-2020
4.3.3 India Oncology Biosimilars Market Size and Price Analysis 2015-2020
4.3.4 Korea Oncology Biosimilars Market Size and Price Analysis 2015-2020
4.4 Europe Country
4.4.1 Germany Oncology Biosimilars Market Size and Price Analysis 2015-2020
4.4.2 UK Oncology Biosimilars Market Size and Price Analysis 2015-2020
4.4.3 France Oncology Biosimilars Market Size and Price Analysis 2015-2020
4.4.4 Italy Oncology Biosimilars Market Size and Price Analysis 2015-2020
4.4.5 Europe Oncology Biosimilars Market Size and Price Analysis 2015-2020
4.5 Other Country and Region
4.5.1 Middle East Oncology Biosimilars Market Size and Price Analysis 2015-2020
4.5.2 Africa Oncology Biosimilars Market Size and Price Analysis 2015-2020
4.5.3 GCC Oncology Biosimilars Market Size and Price Analysis 2015-2020
4.6 Global Oncology Biosimilars Market Segmentation (Region Level) Analysis 2015-2020
4.7 Global Oncology Biosimilars Market Segmentation (Region Level) Analysis
Section 5 Global Oncology Biosimilars Market Segmentation (Product Type Level)
5.1 Global Oncology Biosimilars Market Segmentation (Product Type Level) Market Size 2015-2020
5.2 Different Oncology Biosimilars Product Type Price 2015-2020
5.3 Global Oncology Biosimilars Market Segmentation (Product Type Level) Analysis
Section 6 Global Oncology Biosimilars Market Segmentation (Industry Level)
6.1 Global Oncology Biosimilars Market Segmentation (Industry Level) Market Size 2015-2020
6.2 Different Industry Price 2015-2020
6.3 Global Oncology Biosimilars Market Segmentation (Industry Level) Analysis
Section 7 Global Oncology Biosimilars Market Segmentation (Channel Level)
7.1 Global Oncology Biosimilars Market Segmentation (Channel Level) Sales Volume and Share 2015-2020
7.2 Global Oncology Biosimilars Market Segmentation (Channel Level) Analysis
Section 8 Oncology Biosimilars Market Forecast 2020-2025
8.1 Oncology Biosimilars Segmentation Market Forecast (Region Level)
8.2 Oncology Biosimilars Segmentation Market Forecast (Product Type Level)
8.3 Oncology Biosimilars Segmentation Market Forecast (Industry Level)
8.4 Oncology Biosimilars Segmentation Market Forecast (Channel Level)
Section 9 Oncology Biosimilars Segmentation Product Type
9.1 Drug Class - G-CSF Product Introduction
9.2 Monoclonal Antibodies Product Introduction
9.3 Hematopoietic Agents Product Introduction
Section 10 Oncology Biosimilars Segmentation Industry
10.1 Hospital Pharmacy Clients
10.2 Retail Pharmacy Clients
10.3 Online Pharmacy Clients
Section 11 Oncology Biosimilars Cost of Production Analysis
11.1 Raw Material Cost Analysis
11.2 Technology Cost Analysis
11.3 Labor Cost Analysis
11.4 Cost Overview
Section 12 Conclusion
Chart and Figure
Figure Oncology Biosimilars Product Picture from Celltrion Inc.
Chart 2015-2020 Global Manufacturer Oncology Biosimilars Shipments (Units)
Chart 2015-2020 Global Manufacturer Oncology Biosimilars Shipments Share
Chart 2015-2020 Global Manufacturer Oncology Biosimilars Business Revenue (Million USD)
Chart 2015-2020 Global Manufacturer Oncology Biosimilars Business Revenue Share
Chart Celltrion Inc. Oncology Biosimilars Shipments, Price, Revenue and Gross profit 2015-2020
Chart Celltrion Inc. Oncology Biosimilars Business Distribution
Chart Celltrion Inc. Interview Record (Partly)
Figure Celltrion Inc. Oncology Biosimilars Product Picture
Chart Celltrion Inc. Oncology Biosimilars Business Profile
Table Celltrion Inc. Oncology Biosimilars Product Specification
Chart BioconSTADA Arzneimittel AG Oncology Biosimilars Shipments, Price, Revenue and Gross profit 2015-2020
Chart BioconSTADA Arzneimittel AG Oncology Biosimilars Business Distribution
Chart BioconSTADA Arzneimittel AG Interview Record (Partly)
Figure BioconSTADA Arzneimittel AG Oncology Biosimilars Product Picture
Chart BioconSTADA Arzneimittel AG Oncology Biosimilars Business Overview
Table BioconSTADA Arzneimittel AG Oncology Biosimilars Product Specification
Chart Dr. Reddy’s Laboratories Ltd. Oncology Biosimilars Shipments, Price, Revenue and Gross profit 2015-2020
Chart Dr. Reddy’s Laboratories Ltd. Oncology Biosimilars Business Distribution
Chart Dr. Reddy’s Laboratories Ltd. Interview Record (Partly)
Figure Dr. Reddy’s Laboratories Ltd. Oncology Biosimilars Product Picture
Chart Dr. Reddy’s Laboratories Ltd. Oncology Biosimilars Business Overview
Table Dr. Reddy’s Laboratories Ltd. Oncology Biosimilars Product Specification
3.4 Pfizer Inc. Oncology Biosimilars Business Introduction
…
Chart United States Oncology Biosimilars Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart United States Oncology Biosimilars Sales Price ($/Unit) 2015-2020
Chart Canada Oncology Biosimilars Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart Canada Oncology Biosimilars Sales Price ($/Unit) 2015-2020
Chart South America Oncology Biosimilars Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart South America Oncology Biosimilars Sales Price ($/Unit) 2015-2020
Chart China Oncology Biosimilars Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart China Oncology Biosimilars Sales Price ($/Unit) 2015-2020
Chart Japan Oncology Biosimilars Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart Japan Oncology Biosimilars Sales Price ($/Unit) 2015-2020
Chart India Oncology Biosimilars Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart India Oncology Biosimilars Sales Price ($/Unit) 2015-2020
Chart Korea Oncology Biosimilars Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart Korea Oncology Biosimilars Sales Price ($/Unit) 2015-2020
Chart Germany Oncology Biosimilars Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart Germany Oncology Biosimilars Sales Price ($/Unit) 2015-2020
Chart UK Oncology Biosimilars Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart UK Oncology Biosimilars Sales Price ($/Unit) 2015-2020
Chart France Oncology Biosimilars Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart France Oncology Biosimilars Sales Price ($/Unit) 2015-2020
Chart Italy Oncology Biosimilars Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart Italy Oncology Biosimilars Sales Price ($/Unit) 2015-2020
Chart Europe Oncology Biosimilars Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart Europe Oncology Biosimilars Sales Price ($/Unit) 2015-2020
Chart Middle East Oncology Biosimilars Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart Middle East Oncology Biosimilars Sales Price ($/Unit) 2015-2020
Chart Africa Oncology Biosimilars Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart Africa Oncology Biosimilars Sales Price ($/Unit) 2015-2020
Chart GCC Oncology Biosimilars Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart GCC Oncology Biosimilars Sales Price ($/Unit) 2015-2020
Chart Global Oncology Biosimilars Market Segmentation (Region Level) Sales Volume 2015-2020
Chart Global Oncology Biosimilars Market Segmentation (Region Level) Market size 2015-2020
Chart Oncology Biosimilars Market Segmentation (Product Type Level) Volume (Units) 2015-2020
Chart Oncology Biosimilars Market Segmentation (Product Type Level) Market Size (Million $) 2015-2020
Chart Different Oncology Biosimilars Product Type Price ($/Unit) 2015-2020
Chart Oncology Biosimilars Market Segmentation (Industry Level) Market Size (Volume) 2015-2020
Chart Oncology Biosimilars Market Segmentation (Industry Level) Market Size (Share) 2015-2020
Chart Oncology Biosimilars Market Segmentation (Industry Level) Market Size (Value) 2015-2020
Chart Global Oncology Biosimilars Market Segmentation (Channel Level) Sales Volume (Units) 2015-2020
Chart Global Oncology Biosimilars Market Segmentation (Channel Level) Share 2015-2020
Chart Oncology Biosimilars Segmentation Market Forecast (Region Level) 2020-2025
Chart Oncology Biosimilars Segmentation Market Forecast (Product Type Level) 2020-2025
Chart Oncology Biosimilars Segmentation Market Forecast (Industry Level) 2020-2025
Chart Oncology Biosimilars Segmentation Market Forecast (Channel Level) 2020-2025
Chart Drug Class - G-CSF Product Figure
Chart Drug Class - G-CSF Product Advantage and Disadvantage Comparison
Chart Monoclonal Antibodies Product Figure
Chart Monoclonal Antibodies Product Advantage and Disadvantage Comparison
Chart Hematopoietic Agents Product Figure
Chart Hematopoietic Agents Product Advantage and Disadvantage Comparison
Chart Hospital Pharmacy Clients
Chart Retail Pharmacy Clients
Chart Online Pharmacy Clients
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
| Historical Data (2015-2019) |
|
|
| Influencing Factors |
|
|
| Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|